Analysis of the value of dynamic computed tomography (CT) examination in the diagnosis of early lung cancer.
Análisis del valor del escaneo dinámico realzado por tomografía computarizada (TC) en el diagnóstico de cáncer de pulmón temprano.
Abstract
Early diagnosis and treatment are vital to improving lung cancer patients’ quality of life and survival rate. This study aimed to investigate the value of dynamic enhanced scanning examination by computed tomography (CT) in early lung cancer diagnosis. One hundred and twenty patients with isolated lung nodules were selected to analyze this diagnostic method, using pathological diagnostic results of cancer as the gold standard. Of the 120 patients with isolated pulmonary nodules, the diagnosis was confirmed by pathological examination in 96 patients with early lung cancer (adenocarcinoma of the lung) and 24 patients with benign lung lesions. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of CT dynamic enhancement scans for the diagnosis of early-stage lung cancer were 93.75%, 83.33%, 91.67%, 95.74%, and 76.92%, respectively. Early-stage lung cancer had significantly less blood volume and a noticeably shorter mean time to passage than benign lung lesions (p<0.01). Blood flow and surface permeability were higher in early-stage lung cancer than in benign lung lesions (p<0.05). The areas under the receiver operating characteristic (ROC) curves for blood volume, blood flow, surface permeability, and mean time to passage for the diagnosis of early-stage lung cancer were 0.737, 0.724, 0.779, and 0.946, respectively. In conclusion, CT dynamic enhancement scan has good application value in diagnosing early lung cancer and is worth promoting in clinical practice.
Downloads
References
Iwano S, Ito S, Kamiya S, Ito R, Kato K, Naganawa S. Utility of metabolic parameters on FDG PET/CT in the classification of early-stage lung adenocarcinoma: prediction of pathological invasive size. Clin Nucl Med 2019; 44(7): 560-565.
Vial MR, O’Connell OJ, Grosu HB, Hernandez M, Noor L, Casal RF, Stewart J, Sarkiss M, Jimenez CA, Rice D, Mehran R. Diagnostic performance of endobronchial ultrasound-guided mediastinal lymph node sampling in early stage non-small cell lung cancer: A prospective study. Respirology 2018; 23(1): 76-81.
Huang C, Liang J, Lei X, Xu X, Xiao Z, Luo L. Diagnostic performance of perfusion computed tomography for differentiating lung cancer from benign lesions: a meta-analysis. Med Sci Monit Int Med J Exp Clin Res 2019; 25: 3485.
Zhao Q, Shi CZ, Luo LP. Role of the texture features of images in the diagnosis of solitary pulmonary nodules in different sizes. Chinese J Cancer Res 2014; 26(4): 451.
Wang X, Lv L, Zheng Q, Huang X, Li B. Differential diagnostic value of 64‑slice spiral computed tomography in solitary pulmonary nodule. Exp Ther Med 2018; 15(6): 4703-4708.
Wang XL, Shan W. Application of dynamic CT to identify lung cancer, pulmonary tuberculosis, and pulmonary inflammatory pseudotumor. Eur Rev Med Pharmacol Sci 2017; 21(21): 4804-4809.
Hou H, Xu Z, Zhang H, Xu Y. Combination diagnosis of multitiancer, pulmonary tuberculosis, and pulmonary inflammatory pseudotumor. Eur Rev Med Pharmacol Sci 2017; 21(21): e22250.
Li Y, Yang ZG, Chen TW, Yu JQ, Sun JY, Chen HJ. First-pass perfusion imaging of solitary pulmonary nodules with 64-detector row CT: comparison of perfusion parameters of malignant and benign lesions. Br J Radiol 2010; 83(993): 785-790.
Wang G, Zhou XM, Zhao RR, Xu W, Zhang C, Jiang G, Tang X, Yu H. Multi-slice spiral computed tomography perfusion imaging technology differentiates benign and malignant solitary pulmonary nodules. Biomed Res-India 2017; 28(10): 4605-4609.
Xing N, Cai Z, Zhao S, Yang L. The comparative study of CT perfusion parameters of solitary pulmonary nodules with microvessel density. Chinese J Med Imaging 2009; 19(4): 251-254.
Zhou J, Chen E, Xu H, Ye Q, Li J, Ye S, Cheng Q, Zhao L, Su MY, Wang M. Feasibility and diagnostic performance of Voxelwise Computed Diffusion-Weighted Imaging in breast cancer. J Magn Reson Imaging 2019; 49(6): 1610-1616.
Cui S, Cao Z, Guo W, Yu H, Huang R, Wu Y, Zhou Y. Plasma miRNA-23a and miRNA-451 as candidate biomarkers for early diagnosis of nonsmall cell lung cancer: a case-control study. Nan fang yi ke da xue xue bao= J South Med Univ 2019; 39(6): 705-711.
Chudasama DY, Aladag Z, Felicien MI, Hall M, Beeson J, Asadi N, Gidron Y, Karteris E, Anikin VB. Prognostic value of the DNA integrity index in patients with malignant lung tumors. Oncotarget 2018; 9(30): 21281.
Misawa K, Misawa Y, Imai A, Mochizuki D, Endo S, Mima M, Ishikawa R, Kawasaki H, Yamatodani T, Kanazawa T. Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer. J Cancer 2018; 9(6): 941.
Chang YC, Ding Y, Dong L, Zhu LJ, Jensen R V, Hsiao LL. Differential expression patterns of housekeeping genes increase diagnostic and prognostic value in lung cancer. PeerJ 2018; 6: e4719.
Du Q, Yu R, Wang H. Significance of tumor associated autoantibodies in the early diagnosis of lung cancer. Clin Respir J 2018; 12(6): 2020-2028.
Finazzi T, Ronden-Kianoush MI, Spoelstra FOB, Nossent EJ, Nijman SF, Bahce I, Dickhoff C, Senan S. Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease. Acta Oncol (Madr) 2020; 59(5): 569-573.
